JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.51B |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$818M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$596M |
| 4 |
Eaton
ETN
|
+$577M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$557M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Du Pont De Nemours E I
DD
|
+$1.4B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$727M |
| 3 |
Starbucks
SBUX
|
+$679M |
| 4 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$565M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$458M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 23.54% |
| 2 | Financials | 14.6% |
| 3 | Technology | 12.1% |
| 4 | Healthcare | 9.76% |
| 5 | Consumer Discretionary | 8.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4576
Medpace
MEDP
$17.5B
| $6K | ﹤0.01% |
+200
| New | +$6.11K |
2017 Q3
0 quarters
|
|
4577
VivoSim Labs
VIVS
$2.29M
| $6K | ﹤0.01% |
12
| – | – |
2015 Q4
7 quarters
|
|
|
BEST
4578
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
| $6K | ﹤0.01% |
+25
| New | +$5.78K |
2017 Q3
0 quarters
|
|
4579
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $6K | ﹤0.01% |
72
+10
| +16% | +$767 |
2016 Q4
3 quarters
|
|
4580
DELISTED
Immunogen Inc
IMGN
| $6K | ﹤0.01% |
791
+108
| +16% | +$718 |
2016 Q4
3 quarters
|
|
|
UFAB
4581
DELISTED
Unique Fabricating, Inc.
UFAB
| $6K | ﹤0.01% |
+782
| New | +$6.35K |
2017 Q3
0 quarters
|
|
|
ICOL
4582
DELISTED
iShares MSCI Colombia ETF
ICOL
| $6K | ﹤0.01% |
+400
| New | +$5.79K |
2017 Q3
0 quarters
|
|
|
DWFI
4583
DELISTED
SPDR Dorsey Wright Fixed Income Allocation ETF
DWFI
| $6K | ﹤0.01% |
+220
| New | +$5.65K |
2017 Q3
0 quarters
|
|
|
CEL
4584
DELISTED
Cellcom Israel, Ltd.
CEL
| $6K | ﹤0.01% |
596
| – | – |
2015 Q4
7 quarters
|
|
4585
DELISTED
Stein Mart Inc
SMRT
| $6K | ﹤0.01% |
4,612
-55,842
| -92% | -$72.5K |
2016 Q4
3 quarters
|
|
|
MINI
4586
DELISTED
Mobile Mini Inc
MINI
| $6K | ﹤0.01% |
169
+24
| +17% | +$737 |
2016 Q4
3 quarters
|
|
|
TAO
4587
DELISTED
Invesco China Real Estate ETF
TAO
| $6K | ﹤0.01% |
200
-4,000
| -95% | -$111K |
2017 Q1
2 quarters
|
|
4588
DELISTED
Bebe Stores Inc
BEBE
| $6K | ﹤0.01% |
1,145
+176
| +18% | +$984 |
2016 Q4
3 quarters
|
|
|
SLAI
4589
DELISTED
SOLAI Ltd ADS
SLAI
| $5K | ﹤0.01% |
+6
| New | +$4.56K |
2017 Q3
0 quarters
|
|
4590
iShares MSCI Israel ETF
EIS
$871M
| $5K | ﹤0.01% |
100
| – | – |
2016 Q4
3 quarters
|
|
4591
First Trust Energy AlphaDEX Fund
FXN
$379M
| $5K | ﹤0.01% |
330
-23,838
| -99% | -$317K |
2016 Q1
6 quarters
|
|
4592
Eocene Ltd. Ordinary Shares
EOCN
$3.26M
| – | – |
0
| – | – |
2017 Q3
0 quarters
|
|
4593
Kenon Holdings
KEN
$3.29B
| $5K | ﹤0.01% |
314
| – | – |
2017 Q1
2 quarters
|
|
4594
Madison Covered Call & Equity Strategy Fund
MCN
$112M
| $5K | ﹤0.01% |
+657
| New | +$5.14K |
2017 Q3
0 quarters
|
|
4595
TransAlta
TAC
$4B
| $5K | ﹤0.01% |
934
| – | – |
2014 Q3
12 quarters
|
|
|
ZYNE
4596
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
| $5K | ﹤0.01% |
500
-325,950
| -100% | -$3.45M |
2017 Q1
2 quarters
|
|
|
VIVE
4597
DELISTED
VIVEVE MED INC
VIVE
| $5K | ﹤0.01% |
1
-20
| -95% | -$123K |
2017 Q2
1 quarter
|
|
4598
DELISTED
B Communications Ltd
BCOM
| $5K | ﹤0.01% |
344
| – | – |
2015 Q4
7 quarters
|
|
|
RSYS
4599
DELISTED
Radisys Corp
RSYS
| $5K | ﹤0.01% |
+3,714
| New | +$7.21K |
2017 Q3
0 quarters
|
|
|
NSM
4600
DELISTED
Nationstar Mortgage Holdings
NSM
| $5K | ﹤0.01% |
300
-8,646
| -97% | -$151K |
2015 Q3
8 quarters
|
|
Similar funds
JP Morgan Chase's Q3 2017 Portfolio in Review
As of Q3 2017, JP Morgan Chase held 5,458 positions worth $453B, up 3.6% from $438B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q3 2017 filing shows 501 new, 2,053 increased, 1,909 reduced and 470 closed positions. Its largest new stake was JBG SMITH: 3,403,127 shares worth $116M. The largest sale was Du Pont De Nemours E I, an estimated $1.4B.
By sector, the portfolio is most concentrated in Miscellaneous at 24% of assets, up from 23% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q3 2017 buy was JBG SMITH: 3,403,127 shares worth $116M.
- JP Morgan Chase added most to DuPont de Nemours in Q3 2017, an estimated $1.51B increase.
- JP Morgan Chase's biggest Q3 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $727M.
- JP Morgan Chase fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $1.4B.
- JP Morgan Chase's ten largest holdings make up 18% of its $453B portfolio in Q3 2017.
- JP Morgan Chase opened 501 new positions and closed 470 in Q3 2017.
- JP Morgan Chase's portfolio value rose 3.6% quarter-over-quarter to $453B.
Based on JP Morgan Chase's 13F filing for Q3 2017, filed 9 Nov 2017.